Streetbeat News

Earnings

TBLA

Taboola.Com Ltd (NASDAQ:TBLA) reported Q2 FY23 revenues of $332 million, beating the analyst consensus of $315.44 million, despite a 3.1% YoY decrease. The company also reported an adjusted EPS loss of $(0.00), better than the expected $(0.05) loss. Gross profit slid 16.6% to $97.1 million and operating loss widened to $(25) million. The company saw new wins and renewals from key partners, and significant growth in eCommerce and Taboola News. The company raised its FY23 outlook, expecting revenues of $1.438 billion - $1.469 billion.

Portfolio Pulse from Anusuya Lahiri

August 09, 2023 | 3:22 pm

BOOM

DMC Global reported better-than-expected Q2 financial results, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 3:16 pm

DIOD

Diodes Incorporated reported Q2 financial results and issued Q3 revenue guidance below estimates, causing its shares to trade lower.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 3:14 pm

INSW

International Seaways reported better-than-expected Q2 financial results, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 3:12 pm

BLDP

Ballard Power Systems Inc reported a Q2 FY23 revenue decrease of 27% YoY to $15.30 million, missing the consensus of $15.88 million. The company reported a gross loss of $(3.2) million, compared to $(2.2) million a year ago. However, EPS loss improved to $(0.10) from $(0.19) in 2Q22, beating the consensus of $(0.13). Ballard received ~$25.1 million of new orders in Q2 and delivered orders valued at $15.3 million, resulting in an Order Backlog of ~$147.5 million at the end of the quarter. The company's shares are trading higher by 3.5% at $4.86.

Portfolio Pulse from Akanksha Bakshi

August 09, 2023 | 3:12 pm

CI

CVS

LLY

NVO

UNH

Novo Nordisk's weight loss drug, semaglutide, has shown a 20% reduction in major adverse cardiovascular events in a large scale study. This has positive implications for Eli Lilly's similar weight loss drug, Mounjaro. However, the prospect of insurers needing to cover these expensive drugs has led to a fall in stocks of health insurers like UnitedHealth Group, Cigna Group, and CVS Health Corp. Eli Lilly has reported strong earnings and raised its FY23 guidance. The company also has a promising Alzheimer's drug in the pipeline.

Portfolio Pulse from The Arora Report

August 09, 2023 | 3:10 pm

GO

Grocery Outlet Holding reported better-than-expected Q2 financial results, leading to a rise in its share prices. Credit Suisse also raised the price target for the company's stock from $30 to $33.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 3:09 pm

CAE

CAE reported better-than-expected Q1 financial results and issued FY24 guidance, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 3:07 pm

VSH

Vishay Intertechnology Inc (NYSE:VSH) reported Q2 FY23 net revenue growth of 3.3% Y/Y to $892.11 million, surpassing the consensus of $879.69 million. However, gross margin contracted 140 bps Y/Y to 28.9% and operating margin contracted 238 bps Y/Y to 15.1%. Adjusted EBITDA declined 10.5% Y/Y to $177.97 million. The company held ~$1.1 billion in cash and equivalents. For Q3 FY23, Vishay expects revenue of $840 million-$880 million.

Portfolio Pulse from Akanksha Bakshi

August 09, 2023 | 3:06 pm

LOW

Lowe's Companies (NYSE:LOW) has announced a dividend payout of $1.10 per share, with an annualized dividend yield of 2.19%. The company has shown a steady increase in its dividend per share from $2.13 in 2019 to $3.95 in 2022, and its earnings per share have also increased from $5.58 in 2019 to $13.23 in 2022. This suggests that Lowe's is in good financial health and may continue to distribute profits to its investors.

Portfolio Pulse from Benzinga Insights

August 09, 2023 | 3:05 pm